Inhaled nitric oxide in infants >1500 g and <34 weeks gestation with severe respiratory failure.

J Perinatol

Division of Neonatal and Developmental Medicine, School of Medicine and Lucile Packard Children's Hospital, Stanford University, Palo Alto, CA 94304, USA.

Published: June 2007

Objective: Inhaled nitric oxide (iNO) use in infants >1500 g, but <34 weeks gestation with severe respiratory failure will reduce the incidence of death and/or bronchopulmonary dysplasia (BPD).

Study Design: Infants born at <34 weeks gestation with a birth weight >1500 g with respiratory failure were randomly assigned to receive placebo or iNO.

Results: Twenty-nine infants were randomized. There were no differences in baseline characteristics, but the status at randomization showed a statistically significant difference in the use of high-frequency ventilation (P=0.03). After adjustment for oxygenation index entry strata, there was no difference in death and/or BPD (adjusted relative risk (RR) 0.80, 95% confidence interval (CI) 0.43 to 1.48; P=0.50), death (adjusted RR 1.26, 95% CI 0.47 to 3.41; P=0.65) or BPD (adjusted RR 0.40, 95% CI 0.47 to 3.41; P=0.21).

Conclusions: Although sample size limits our ability to make definitive conclusions, this small pilot trial of iNO use in premature infants >1500 g and <34 weeks with severe respiratory failure suggests that iNO does not affect the rate of BPD and/or death.

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.jp.7211690DOI Listing

Publication Analysis

Top Keywords

inhaled nitric
4
nitric oxide
4
oxide infants
4
infants >1500
4
>1500 1500
4
1500 1500
4
0
2
inhaled
1
oxide
1
infants
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!